Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 70.14 USD -2.34% Market Closed
Market Cap: 12.1B USD
Have any thoughts about
Insmed Inc?
Write Note

Wall Street
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 90.46 USD with a low forecast of 74.74 USD and a high forecast of 108.15 USD.

Lowest
Price Target
74.74 USD
7% Upside
Average
Price Target
90.46 USD
29% Upside
Highest
Price Target
108.15 USD
54% Upside

INSM Last Price Targets
Insmed Inc

The latest public price target was made on Aug 15, 2024 by Graig Suvannavejh from Mizuho Securities , who expects INSM stock to rise by 31% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Graig Suvannavejh
Mizuho Securities
92 USD
Upside 31%
2 months ago
Aug 15, 2024
Insmed (INSM) PT Raised to $92 at Mizuho, 'continue to favor it as our top longer-term idea'
StreetInsider
Tiago Fauth
Wells Fargo
85 USD
Upside 21%
3 months ago
Aug 9, 2024
Insmed price target raised to $85 from $77 at Wells Fargo
TheFly
Vamil Divan
Guggenheim
95 USD
Upside 35%
4 months ago
Jul 9, 2024
Insmed price target raised to $95 from $70 at Guggenheim
TheFly
Nicole Germino
Truist Financial
88 USD
Upside 25%
4 months ago
Jul 1, 2024
Insmed (INSM) PT Raised to $88 at Truist Securities
StreetInsider
Leon Wang
Barclays
90 USD
Upside 28%
4 months ago
Jun 25, 2024
Insmed (INSM) PT Raised to $90 at Barclays
StreetInsider
Liisa Bayko
Evercore ISI
75 USD
Upside 7%
4 months ago
Jun 21, 2024
Insmed (INSM) PT Raised to $75 at Evercore ISI
StreetInsider
Graig Suvannavejh
Mizuho Securities
82 USD
Upside 17%
5 months ago
Jun 7, 2024
Insmed (INSM) PT Raised to $82 at Mizuho
StreetInsider
Stephen Willey
Stifel Nicolaus
74 USD
Upside 6%
5 months ago
Jun 5, 2024
Insmed price target raised to $74 from $67 at Stifel
TheFly
Nicole Germino
Truist Financial
68 USD
Downside 3%
5 months ago
May 29, 2024
Insmed (INSM) PT Raised to $68 at Truist Securities
StreetInsider
Andrew Fein
H.C. Wainwright
70 USD
Downside 0%
5 months ago
May 29, 2024
Insmed (INSM) PT Raised to $70 at H.C. Wainwright
StreetInsider
Andy Chen
Wolfe Research
54 USD
Downside 23%
5 months ago
May 29, 2024
Insmed (INSM) PT Raised to $54 at Wolfe Research
StreetInsider
Tiago Fauth
Wells Fargo
77 USD
Upside 10%
5 months ago
May 29, 2024
Insmed (INSM) PT Raised to $77 at Wells Fargo
StreetInsider
Trung Huynh
UBS
58 USD
Downside 17%
5 months ago
May 29, 2024
Insmed (INSM) PT Raised to $58 at UBS
StreetInsider
Andrea Tan
Goldman Sachs
74 USD
Upside 6%
5 months ago
May 28, 2024
Goldman Sachs Reiterates Buy Rating on Insmed (INSM)
StreetInsider
Jeffrey Hung
Morgan Stanley
60 USD
Downside 14%
5 months ago
May 28, 2024
Insmed (INSM) PT Raised to $60 at Morgan Stanley
StreetInsider
Liisa Bayko
Evercore ISI
42 USD
Downside 40%
5 months ago
May 28, 2024
Evercore ISI Reiterates Outperform Rating on Insmed (INSM)
StreetInsider
Graig Suvannavejh
Mizuho Securities
36 USD
Downside 49%
6 months ago
May 13, 2024
Insmed (INSM) PT Raised to $36 at Mizuho
StreetInsider
Jeffrey Hung
Morgan Stanley
43 USD
Downside 39%
6 months ago
May 9, 2024
Insmed (INSM) PT Raised to $43 at Morgan Stanley
StreetInsider
Nicole Germino
Truist Financial
48 USD
Downside 32%
6 months ago
Apr 23, 2024
Truist Securities Starts Insmed (INSM) at Buy
StreetInsider
Tiago Fauth
Wells Fargo
55 USD
Downside 22%
7 months ago
Apr 1, 2024
Wells Fargo Adds Insmed (INSM) to Q2 '24 Tactical Idea List
StreetInsider
Show More Price Targets
Show Less Price Targets
Graig Suvannavejh
Mizuho Securities
Price Target 92 USD
Upside/Downside 31%
View Source
Tiago Fauth
Wells Fargo
Price Target 85 USD
Upside/Downside 21%
View Source
Vamil Divan
Guggenheim
Price Target 95 USD
Upside/Downside 35%
View Source
Nicole Germino
Truist Financial
Price Target 88 USD
Upside/Downside 25%
View Source
Leon Wang
Barclays
Price Target 90 USD
Upside/Downside 28%
View Source
Liisa Bayko
Evercore ISI
Price Target 75 USD
Upside/Downside 7%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 82 USD
Upside/Downside 17%
View Source
Stephen Willey
Stifel Nicolaus
Price Target 74 USD
Upside/Downside 6%
View Source
Nicole Germino
Truist Financial
Price Target 68 USD
Upside/Downside 3%
View Source
Andrew Fein
H.C. Wainwright
Price Target 70 USD
Upside/Downside 0%
View Source
Andy Chen
Wolfe Research
Price Target 54 USD
Upside/Downside 23%
View Source
Tiago Fauth
Wells Fargo
Price Target 77 USD
Upside/Downside 10%
View Source
Trung Huynh
UBS
Price Target 58 USD
Upside/Downside 17%
View Source
Andrea Tan
Goldman Sachs
Price Target 74 USD
Upside/Downside 6%
View Source
Jeffrey Hung
Morgan Stanley
Price Target 60 USD
Upside/Downside 14%
View Source
Liisa Bayko
Evercore ISI
Price Target 42 USD
Upside/Downside 40%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 36 USD
Upside/Downside 49%
View Source
Jeffrey Hung
Morgan Stanley
Price Target 43 USD
Upside/Downside 39%
View Source
Nicole Germino
Truist Financial
Price Target 48 USD
Upside/Downside 32%
View Source
Tiago Fauth
Wells Fargo
Price Target 55 USD
Upside/Downside 22%
View Source
Show More Price Targets
Show Less Price Targets
Insmed Inc Competitors:
Price Targets
UTHR
United Therapeutics Corp
4% Downside
206650
EuBiologics Co Ltd
9% Downside
CDMO
Avid Bioservices Inc
13% Upside
ALERS
Eurobio Scientific SA
19% Upside
084650
Labgenomics Co Ltd
77% Upside
EXAI
Exscientia PLC
6% Downside
DNLI
Denali Therapeutics Inc
39% Upside
MREO
Mereo Biopharma Group PLC
79% Upside

Revenue
Forecast

Revenue Estimate
Insmed Inc

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INSM's stock price target?
Price Target
90.46 USD

According to Wall Street analysts, the average 1-year price target for INSM is 90.46 USD with a low forecast of 74.74 USD and a high forecast of 108.15 USD.

What is Insmed Inc's Revenue forecast?
Projected CAGR
52%

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 52%.

Back to Top